Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07265908

Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

The REPRO-Biobank has been established at San Raffaele Hospital in Milan for the purpose of collecting and preserving human biological samples and associated data. Its primary objective is to support biomedical research, with a particular focus on advancing scientific knowledge - including in the field of genetics - related to gynecological disorders, male and female infertility, and pregnancy-related conditions.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • Affected participants

Inclusion criteria

for adult patients (including pregnant and breastfeeding women) and pediatric patients affected by:

  • Male infertility
  • Female infertility
  • Gynecological disorders
  • Pregnancy-related conditions
  • Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation)
  • Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients

Exclusion criteria

  • Patients unable or unwilling to sign the informed consent
  • Healthy participants Inclusion Criteria
  • Healthy adult subjects (including pregnant and lactating women)
  • Able to give informed consent for participation in the study

Exclusion criteria

  • Patients unable or unwilling to sign the informed consent

Treatment and study plan

Blood sampling

Other

Blood sampling

Primary outcomes

  1. Developing a biobank/repository

    Time frame: Through study completion, an average of 1 year.

Sponsors and collaborators

Lead sponsor

IRCCS San Raffaele

Other

Registry information

Official study title

Establishment of a Biobank Aimed at Studying Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

Important dates

Study start
2024
Primary completion
2043
Study completion
2043
First posted
Dec 5, 2025
Registry last updated
Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.